Zacks Investment Research on MSN

Novavax grants license for use of Matrix-M adjuvant to Pfizer

Novavax NVAX announced a non-exclusive license agreement with Pfizer PFE, granting the latter access to its proprietary ...

Here's Why Pfizer Is Willing To Pay $500 Million For Novavax's Matrix-M

Novavax’s Pfizer Matrix-M licensing deal brings $30M upfront, milestones & royalties. Read the full analysis here.

Everything to Know About The Matrix Treatment by Candela (From Someone Who Tried It)

I've always been someone who gets the occasional pre-period breakout, but after having a baby two years ago, postpartum ...